Skip to content

Clinical trials

Esophageal Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Country / region: Brazil Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20142
20151
20161
20172
20191
20201
20211
20221
20234
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed5
Unknown status3
Active, not recruiting2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Instituto do Cancer do Estado de São Paulo5
Merck Sharp & Dohme LLC5
AstraZeneca2
Fauze Maluf Filho2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Eurofarma Laboratorios S.A.1
Instituto Nacional de Cancer, Brazil1
Jazz Pharmaceuticals1
Novartis Pharmaceuticals1
Universidade Federal de Pernambuco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms20
Stomach Neoplasms6
Head and Neck Neoplasms4
Adenocarcinoma3
Prostatic Neoplasms3
Breast Neoplasms2
Deglutition Disorders2
Esophageal Squamous Cell Carcinoma2
Kidney Neoplasms2
Neoplasms2

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.